Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier de Gracia

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Open Respiratory Medicine Journal|April 21, 2015
Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasisMontserrat Vendrell, Gerard Muñoz, Javier de Gracia
Archivos De Bronconeumologia|December 8, 2009
[Hard metal interstitial lung disease]M Angeles Montero, Javier de Gracia, Ferràn Morell
Medicina Clinica|April 12, 2003
[Acute pancreatitis as a first manifestation of cystic fibrosis]Sergio Ledesma, Antonio Alvarez, Miguel Torres, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 4, 2005
[Nocardiosis and bronchiectasis. An uncommon association?]Adelaida Ferrer, Víctor Llorenç, Gemma Codina, et al.
Medicina Clinica|April 14, 2009
[Bronchiectasis treatment in adults]Miguel Angel Martínez García, Luis Máiz Carro, Javier de Gracia Roldán
The European Respiratory Journal|January 13, 2018
Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trialGerard Muñoz, Javier de Gracia, Maria Buxó, et al.
Chest|April 12, 2002
Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosisFerran Morell, Gur Levy, Ramon Orriols, et al.
Archivos De Bronconeumologia|June 28, 2011
[The future of inhaled antibiotic therapy. New products]Montserrat Vendrell Relat, Gerard Muñoz Castro, Gladis Sabater Talaverano, et al.
Archivos De Bronconeumologia|April 22, 2008
[Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease]Ferran Morell, Leonardo Reyes, Gema Doménech, et al.
International Immunopharmacology|February 3, 2005
A prospective controlled crossover trial of a new presentation (10% vs. 5%) of a heat-treated intravenous immunoglobulinNúria Matamoros, Javier De Gracia, Fernando Hernández, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Open Respiratory Medicine Journal|April 21, 2015
Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasisMontserrat Vendrell, Gerard Muñoz, Javier de Gracia
Archivos De Bronconeumologia|December 8, 2009
[Hard metal interstitial lung disease]M Angeles Montero, Javier de Gracia, Ferràn Morell
Medicina Clinica|April 12, 2003
[Acute pancreatitis as a first manifestation of cystic fibrosis]Sergio Ledesma, Antonio Alvarez, Miguel Torres, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 4, 2005
[Nocardiosis and bronchiectasis. An uncommon association?]Adelaida Ferrer, Víctor Llorenç, Gemma Codina, et al.
Medicina Clinica|April 14, 2009
[Bronchiectasis treatment in adults]Miguel Angel Martínez García, Luis Máiz Carro, Javier de Gracia Roldán
The European Respiratory Journal|January 13, 2018
Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trialGerard Muñoz, Javier de Gracia, Maria Buxó, et al.
Chest|April 12, 2002
Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosisFerran Morell, Gur Levy, Ramon Orriols, et al.
Archivos De Bronconeumologia|June 28, 2011
[The future of inhaled antibiotic therapy. New products]Montserrat Vendrell Relat, Gerard Muñoz Castro, Gladis Sabater Talaverano, et al.
Archivos De Bronconeumologia|April 22, 2008
[Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease]Ferran Morell, Leonardo Reyes, Gema Doménech, et al.
International Immunopharmacology|February 3, 2005
A prospective controlled crossover trial of a new presentation (10% vs. 5%) of a heat-treated intravenous immunoglobulinNúria Matamoros, Javier De Gracia, Fernando Hernández, et al.
Pageof 6